PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes.
Jaquellyne Gurgel Penaforte-SaboiaCarlos Eduardo Barra CouriNatasha Vasconcelos AlbuquerqueLana Livia Peixoto LinardDaniel Autran Cavalcante AraújoSherida Karanini Paz de OliveiraThisciane Ferreira Pinto GomesMarcelo Maia PinheiroMaria Helane Costa Gurgel CasteloVirginia Oliveira FernandesRenan Magalhães Montenegro JúniorPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2024)
Brazilian Registry of Clinical Trials.